4 results on '"Srini, Vasan Satya"'
Number of results to display per page
Search Results
2. Male Oxidative Stress Infertility (MOSI): Proposed Terminology and Clinical Practice Guidelines for Management of Idiopathic Male Infertility
- Author
-
Agarwal, Ashok, Parekh, Neel, Selvam, Manesh Kumar Panner, Henkel, Ralf, Shah, Rupin, Homa, Sheryl T., Ramasamy, Ranjith, Ko, Edmund, Tremellen, Kelton, Esteves, Sandro, Majzoub, Ahmad, Alvarez, Juan G., Gardner, David K., Jayasena, Channa N., Ramsay, Jonathan W., Cho, Chak-Lam, Saleh, Ramadan, Sakkas, Denny, Hotaling, James M., Lundy, Scott D., Vij, Sarah, Marmar, Joel, Gosalvez, Jaime, Sabanegh, Edmund, Park, Hyun Jun, Zini, Armand, Kavoussi, Parviz, Micic, Sava, Smith, Ryan, Busetto, Gian Maria, Bakircioglu, Mustafa Emre, Haidl, Gerhard, Balercia, Giancarlo, Garrido Puchalt, Nicols, Ben-Khalifa, Moncef, Tadros, Nicholas, Kirkman-Browne, Jackson, Moskovtsev, Sergey, Huang, Xuefeng, Borges, Edson, Jr., Franken, Daniel, Bar-Chama, Natan, Morimoto, Yoshiharu, Tomita, Kazuhisa, Srini, Vasan Satya, Ombelet, Willem, Baldi, Elisabetta, Muratori, Monica, Yumura, Yasushi, La Vignera, Sandro, Kosgi, Raghavender, Martinez, Marlon P., Evenson, Donald P., Zylbersztejn, Daniel Suslik, Roque, Matheus, Cocuzza, Marcello, Vieira, Marcelo, Ben-Meir, Assaf, Orvieto, Raoul, Levitas, Eliahu, Wiser, Amir, Arafa, Mohamed, Malhotra, Vineet, Parekattil, Sijo Joseph, Elbardisi, Haitham, Carvalho, Luiz, Dada, Rima, Sifer, Christophe, Talwar, Pankaj, Gudeloglu, Ahmet, Mahmoud, Ahmed M. A., Terras, Khaled, Yazbeck, Chadi, Nebojsa, Bojanic, Durairajanayagam, Damayanthi, Mounir, Ajina, Kahn, Linda G., Baskaran, Saradha, Pai, Rishma Dhillon, Paoli, Donatella, Leisegang, Kristian, Moein, Mohamed-Reza, Malik, Sonia, Yaman, Onder, Samanta, Luna, Bayane, Fouad, Jindal, Sunil K., Kendirci, Muammer, Altay, Baris, Perovic, Dragoljub, Harlev, Avi, and Ege Üniversitesi
- Subjects
Oxidative stress ,Semen ,Oxidation reduction potential ,MOSI ,Infertility, male - Abstract
WOS: 000482196700006, PubMed ID: 31081299, Despite advances in the field of male reproductive health, idiopathic male infertility, in which a man has altered semen characteristics without an identifiable cause and there is no female factor infertility, remains a challenging condition to diagnose and manage. Increasing evidence suggests that oxidative stress (OS) plays an independent role in the etiology of male infertility, with 30% to 80% of infertile men having elevated seminal reactive oxygen species levels. OS can negatively affect fertility via a number of pathways, including interference with capacitation and possible damage to sperm membrane and DNA, which may impair the sperm's potential to fertilize an egg and develop into a healthy embryo. Adequate evaluation of male reproductive potential should therefore include an assessment of sperm OS. We propose the term Male Oxidative Stress Infertility, or MOSI, as a novel descriptor for infertile men with abnormal semen characteristics and OS, including many patients who were previously classified as having idiopathic male infertility. Oxidation-reduction potential (ORP) can be a useful clinical biomarker for the classification of MOSI, as it takes into account the levels of both oxidants and reductants (antioxidants). Current treatment protocols for OS, including the use of antioxidants, are not evidence-based and have the potential for complications and increased healthcare-related expenditures. Utilizing an easy, reproducible, and cost-effective test to measure ORP may provide a more targeted, reliable approach for administering antioxidant therapy while minimizing the risk of antioxidant overdose. With the increasing awareness and understanding of MOSI as a distinct male infertility diagnosis, future research endeavors can facilitate the development of evidence-based treatments that target its underlying cause., American Center for Reproductive Medicine, Financial support for this study was provided by the American Center for Reproductive Medicine.
- Published
- 2019
3. Male Oxidative Stress Infertility (MOSI): Proposed Terminology and Clinical Practice Guidelines for Management of Idiopathic Male Infertility
- Author
-
Agarwal, Ashok, primary, Parekh, Neel, additional, Panner Selvam, Manesh Kumar, additional, Henkel, Ralf, additional, Shah, Rupin, additional, Homa, Sheryl T., additional, Ramasamy, Ranjith, additional, Ko, Edmund, additional, Tremellen, Kelton, additional, Esteves, Sandro, additional, Majzoub, Ahmad, additional, Alvarez, Juan G., additional, Gardner, David K., additional, Jayasena, Channa N., additional, Ramsay, Jonathan W., additional, Cho, Chak-Lam, additional, Saleh, Ramadan, additional, Sakkas, Denny, additional, Hotaling, James M., additional, Lundy, Scott D., additional, Vij, Sarah, additional, Marmar, Joel, additional, Gosalvez, Jaime, additional, Sabanegh, Edmund, additional, Park, Hyun Jun, additional, Zini, Armand, additional, Kavoussi, Parviz, additional, Micic, Sava, additional, Smith, Ryan, additional, Busetto, Gian Maria, additional, Bakırcıoğlu, Mustafa Emre, additional, Haidl, Gerhard, additional, Balercia, Giancarlo, additional, Puchalt, Nicolás Garrido, additional, Ben-Khalifa, Moncef, additional, Tadros, Nicholas, additional, Kirkman-Browne, Jackson, additional, Moskovtsev, Sergey, additional, Huang, Xuefeng, additional, Borges, Edson, additional, Franken, Daniel, additional, Bar-Chama, Natan, additional, Morimoto, Yoshiharu, additional, Tomita, Kazuhisa, additional, Srini, Vasan Satya, additional, Ombelet, Willem, additional, Baldi, Elisabetta, additional, Muratori, Monica, additional, Yumura, Yasushi, additional, La Vignera, Sandro, additional, Kosgi, Raghavender, additional, Martinez, Marlon P., additional, Evenson, Donald P., additional, Zylbersztejn, Daniel Suslik, additional, Roque, Matheus, additional, Cocuzza, Marcello, additional, Vieira, Marcelo, additional, Ben-Meir, Assaf, additional, Orvieto, Raoul, additional, Levitas, Eliahu, additional, Wiser, Amir, additional, Arafa, Mohamed, additional, Malhotra, Vineet, additional, Parekattil, Sijo Joseph, additional, Elbardisi, Haitham, additional, Carvalho, Luiz, additional, Dada, Rima, additional, Sifer, Christophe, additional, Talwar, Pankaj, additional, Gudeloglu, Ahmet, additional, Mahmoud, Ahmed M.A., additional, Terras, Khaled, additional, Yazbeck, Chadi, additional, Nebojsa, Bojanic, additional, Durairajanayagam, Damayanthi, additional, Mounir, Ajina, additional, Kahn, Linda G., additional, Baskaran, Saradha, additional, Pai, Rishma Dhillon, additional, Paoli, Donatella, additional, Leisegang, Kristian, additional, Moein, Mohamed-Reza, additional, Malik, Sonia, additional, Yaman, Onder, additional, Samanta, Luna, additional, Bayane, Fouad, additional, Jindal, Sunil K., additional, Kendirci, Muammer, additional, Altay, Baris, additional, Perovic, Dragoljub, additional, and Harlev, Avi, additional
- Published
- 2019
- Full Text
- View/download PDF
4. Low intensity extracorporeal shockwave therapy for erectile dysfunction: a study in an Indian population.
- Author
-
Srini VS, Reddy RK, Shultz T, and Denes B
- Subjects
- Double-Blind Method, Hemodynamics, Humans, India, Male, Penile Erection, Penis blood supply, Phosphodiesterase 5 Inhibitors therapeutic use, Severity of Illness Index, High-Energy Shock Waves therapeutic use, Impotence, Vasculogenic therapy
- Abstract
Introduction: Erectile dysfunction (ED) has been shown to be associated with a number of physical conditions and affects not only physical but also psychosocial health. Currently oral, on-demand phosphodiesterase type 5 inhibitors (PDE5i) are preferred first line treatment. Though effective, these drugs have limitations and are associated with significant non-compliance, side effects and do not reverse the underlying pathology. Non-invasive low intensity shockwave therapy (LISWT) has been shown to significantly improve erectile function in men previously PDE5i dependent. We describe our experience and results with this therapy in an Indian population of men with ED. This study assessed the efficacy of low intensity extracorporeal shockwave therapy (LI-ESWT) on Indian men with organic ED who had previously responded to PDE5i., Materials and Methods: All the patients underwent a 1 month PDE5i washout period. Men were randomized to receive either 12 sessions of LI-ESWT (n = 95) or placebo/sham therapy (n = 40). Before the first treatment, erectile function and penile hemodynamics were assessed to substantiate a vascular etiology for the ED. Outcomes were assessed using Erection Hardness Score (EHS), International Index of Erectile Function-Erectile Function Domain (IIEF-EF domain) and Clinical Global Impression of Change (CGIC) scores at 1, 3, 6, 9 and 12 months post-treatment., Results: We found a significant increase in the EHS and IIEF-EF Domain scores from visit 1 to follow up 5 (12 months) in the treated group compared to the placebo group. By 1 month after treatment there were highly significant differences between the LI-ESWT and placebo groups (p < 0.0001). Out of 60 men in the LI-ESWT group who completed the study, 47 (78%) men at FU1 and 43 (71%) at FU5 who were initially unable to achieve spontaneous erections hard enough for penetration (EHS ≤ 2) were able to do so (EHS ≥ 3) compared to none in the placebo group. The treatment was well tolerated and none of the men experienced treatment related discomfort or reported any adverse effects from the treatment., Conclusions: In this double-blind, placebo-controlled study, LI-ESWT demonstrated a positive long term clinical effect with improvement in erectile function of Indian men with vasculogenic ED who were prior responders to PDE5i therapy. The efficacy and tolerability of this treatment, coupled with its long term benefits and rehabilitative characteristics, make it an attractive new therapeutic option for men with vasculogenic erectile dysfunction.
- Published
- 2015
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.